These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 33298542)
21. Emergence of broadly neutralizing antibodies and viral coevolution in two subjects during the early stages of infection with human immunodeficiency virus type 1. Sather DN; Carbonetti S; Malherbe DC; Pissani F; Stuart AB; Hessell AJ; Gray MD; Mikell I; Kalams SA; Haigwood NL; Stamatatos L J Virol; 2014 Nov; 88(22):12968-81. PubMed ID: 25122781 [TBL] [Abstract][Full Text] [Related]
22. Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection. Awan SF; Happe M; Hofstetter AR; Gama L Curr Opin HIV AIDS; 2022 Jul; 17(4):247-257. PubMed ID: 35762380 [TBL] [Abstract][Full Text] [Related]
23. A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies. Davis-Gardner ME; Alfant B; Weber JA; Gardner MR; Farzan M mBio; 2020 Jan; 11(1):. PubMed ID: 31937648 [TBL] [Abstract][Full Text] [Related]
24. Neutralization Synergy between HIV-1 Attachment Inhibitor Fostemsavir and Anti-CD4 Binding Site Broadly Neutralizing Antibodies against HIV. Zhang Y; Chapman JH; Ulcay A; Sutton RE J Virol; 2019 Feb; 93(4):. PubMed ID: 30518644 [TBL] [Abstract][Full Text] [Related]
32. Complementary Roles of Antibody Heavy and Light Chain Somatic Hypermutation in Conferring Breadth and Potency to the HIV-1-Specific CAP256-VRC26 bNAb Lineage. Sacks D; Wiehe K; Morris L; Moore PL J Virol; 2022 May; 96(10):e0027022. PubMed ID: 35510865 [TBL] [Abstract][Full Text] [Related]
33. Neutralization Breadth and Potency of Single-Chain Variable Fragments Derived from Broadly Neutralizing Antibodies Targeting Multiple Epitopes on the HIV-1 Envelope. van Dorsten RT; Lambson BE; Wibmer CK; Weinberg MS; Moore PL; Morris L J Virol; 2020 Jan; 94(2):. PubMed ID: 31619559 [TBL] [Abstract][Full Text] [Related]
34. Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection. Cohen YZ; Caskey M Curr Opin HIV AIDS; 2018 Jul; 13(4):366-373. PubMed ID: 29697469 [TBL] [Abstract][Full Text] [Related]
35. Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope. Doores KJ; Kong L; Krumm SA; Le KM; Sok D; Laserson U; Garces F; Poignard P; Wilson IA; Burton DR J Virol; 2015 Jan; 89(2):1105-18. PubMed ID: 25378488 [TBL] [Abstract][Full Text] [Related]
36. Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses. Tu JJ; Kumar A; Giorgi EE; Eudailey J; LaBranche CC; Martinez DR; Fouda GG; Moreau Y; Thomas A; Montefiori D; Gao F; Sagar M; Permar SR J Virol; 2022 Jun; 96(11):e0023122. PubMed ID: 35536018 [TBL] [Abstract][Full Text] [Related]
37. Broadly neutralizing plasma antibodies effective against autologous circulating viruses in infants with multivariant HIV-1 infection. Mishra N; Sharma S; Dobhal A; Kumar S; Chawla H; Singh R; Makhdoomi MA; Das BK; Lodha R; Kabra SK; Luthra K Nat Commun; 2020 Sep; 11(1):4409. PubMed ID: 32879304 [TBL] [Abstract][Full Text] [Related]